SEC Form 4 · accession 0001638599-16-000879
ALBANY MOLECULAR RESEARCH INC · AMRI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven R Hagen
Officer — SVP Manufacturing & Pharmaceut
Period of report
May 13, 2016
Accepted (ET)
May 16, 2016 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001065087
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 13, 2016 | S | 2,361 | $12.77 | D | 37,564 | D |
Table II — derivative securities
No Table II lines on this filing.